These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 9228385
1. Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancer. Kelley MJ, Linnoila RI, Avis IL, Georgiadis MS, Cuttitta F, Mulshine JL, Johnson BE. Chest; 1997 Jul; 112(1):256-61. PubMed ID: 9228385 [Abstract] [Full Text] [Related]
2. Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer. Chaudhry A, Carrasquillo JA, Avis IL, Shuke N, Reynolds JC, Bartholomew R, Larson SM, Cuttitta F, Johnson BE, Mulshine JL. Clin Cancer Res; 1999 Nov; 5(11):3385-93. PubMed ID: 10589749 [Abstract] [Full Text] [Related]
4. Preclinical evaluation of an anti-autocrine growth factor monoclonal antibody for treatment of patients with small-cell lung cancer. Avis IL, Kovacs TO, Kasprzyk PG, Treston AM, Bartholomew R, Walsh JH, Cuttitta F, Mulshine JL. J Natl Cancer Inst; 1991 Oct 16; 83(20):1470-6. PubMed ID: 1656058 [Abstract] [Full Text] [Related]
5. Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer. Siegfried JM, Krishnamachary N, Gaither Davis A, Gubish C, Hunt JD, Shriver SP. Pulm Pharmacol Ther; 1999 Oct 16; 12(5):291-302. PubMed ID: 10545285 [Abstract] [Full Text] [Related]
6. Autocrine growth factors and neuroendocrine markers in the development of small-cell lung cancer. Johnson BE, Kelley MJ. Oncology (Williston Park); 1998 Jan 16; 12(1 Suppl 2):11-4. PubMed ID: 9516605 [Abstract] [Full Text] [Related]
7. Anti-bombesin monoclonal antibodies modulate fetal mouse lung growth and maturation in utero and in organ cultures. Sunday ME, Hua J, Reyes B, Masui H, Torday JS. Anat Rec; 1993 May 16; 236(1):25-32; discussion 33-4. PubMed ID: 8507013 [Abstract] [Full Text] [Related]
8. Clinical use of a monoclonal antibody to bombesin-like peptide in patients with lung cancer. Mulshine JL, Avis I, Treston AM, Mobley C, Kaspryzyk P, Carrasquillo JA, Larson SM, Nakanishi Y, Merchant B, Minna JD. Ann N Y Acad Sci; 1988 May 16; 547():360-72. PubMed ID: 2853598 [No Abstract] [Full Text] [Related]
9. Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095. Halmos G, Schally AV. Proc Natl Acad Sci U S A; 1997 Feb 04; 94(3):956-60. PubMed ID: 9023364 [Abstract] [Full Text] [Related]
10. Gastrin-releasing peptide receptor-mediated autocrine growth in squamous cell carcinoma of the head and neck. Lango MN, Dyer KF, Lui VW, Gooding WE, Gubish C, Siegfried JM, Grandis JR. J Natl Cancer Inst; 2002 Mar 06; 94(5):375-83. PubMed ID: 11880476 [Abstract] [Full Text] [Related]
20. Antitumoral activity of bombesin analogues on small cell lung cancer xenografts: relationship with bombesin receptor expression. Thomas F, Arvelo F, Antoine E, Jacrot M, Poupon MF. Cancer Res; 1992 Sep 15; 52(18):4872-7. PubMed ID: 1325285 [Abstract] [Full Text] [Related] Page: [Next] [New Search]